MHRA on reboxetine :: Pharmacy Daily pharmacy industry news
THE UK Medicines and Healthcare products Regulatory Agency has published a review of reboxetine, which found that the drug is statistically significantly more effective than placebo in the treatment of patients with severe clinical depression.
1 min read